We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,802 hedge funds and large institutions have $249B invested in Johnson & Johnson in 2024 Q2 according to their latest regulatory filings, with 162 funds opening new positions, 1,507 increasing their positions, 1,791 reducing their positions, and 154 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more call options, than puts

Call options by funds: $2.12B | Put options by funds: $1.78B

1.01% more ownership

Funds ownership: 69.87%70.88% (+1%)

5% more first-time investments, than exits

New positions opened: 162 | Existing positions closed: 154

1% less funds holding

Funds holding: 3,8493,802 (-47)

6% less capital invested

Capital invested by funds: $266B → $249B (-$16.5B)

16% less repeat investments, than reductions

Existing positions increased: 1,507 | Existing positions reduced: 1,791

19% less funds holding in top 10

Funds holding in top 10: 204165 (-39)

Holders
3,802
Holders Change
-47
Holders Change %
-1.22%
% of All Funds
54.9%
Holding in Top 10
165
Holding in Top 10 Change
-39
Holding in Top 10 Change %
-19.12%
% of All Funds
2.38%
New
162
Increased
1,507
Reduced
1,791
Closed
154
Calls
$2.12B
Puts
$1.78B
Net Calls
+$333M
Net Calls Change
-$99.1M
Name Holding Trade Value Shares
Change
Change in
Stake
1IA
1001
1834 Investment Advisors
Wisconsin
$7.71M -$112K -750 -1%
MCG
1002
McCollum Christoferson Group
New York
$7.67M -$159K -1,071 -2%
FA
1003
Fagan Associates
New York
$7.66M -$93.1K -626 -1%
QP
1004
Quilter Plc
United Kingdom
$7.65M -$1.15M -7,732 -13%
CWG
1005
Cornerstone Wealth Group
North Carolina
$7.64M -$66.5K -447 -0.8%
LWANC
1006
Laurel Wealth Advisors (North Carolina)
North Carolina
$7.63M -$496K -3,332 -6%
BP
1007
Ballentine Partners
Massachusetts
$7.62M -$45.8K -308 -0.6%
AOWM
1008
Alpha Omega Wealth Management
Virginia
$7.61M -$86.3K -580 -1%
MCM
1009
Mengis Capital Management
Oregon
$7.6M -$810K -5,446 -9%
FSA
1010
Fort Sheridan Advisors
Illinois
$7.58M +$680K +4,573 +10%
TFM
1011
TFC Financial Management
Massachusetts
$7.57M -$317K -2,129 -4%
KCPG
1012
Kavar Capital Partners Group
Kansas
$7.55M -$165K -1,107 -2%
HW
1013
Hancock Whitney
Mississippi
$7.55M -$240K -1,612 -3%
CCG
1014
Chatham Capital Group
Georgia
$7.54M +$58.2K +391 +0.8%
MIG
1015
McGuire Investment Group
Rhode Island
$7.53M -$524K -3,524 -6%
SGC
1016
Slocum, Gordon & Co
Rhode Island
$7.53M -$57.9K -389 -0.7%
HIA
1017
Harbor Investment Advisory
Maryland
$7.53M +$128K +863 +2%
KNW
1018
Kesler Norman & Wride
Utah
$7.5M +$414K +2,786 +6%
SCP
1019
Stamos Capital Partners
California
$7.5M +$354K +2,380 +5%
PA
1020
Perennial Advisors
New York
$7.5M -$136K -914 -2%
NRG
1021
Nemes Rush Group
Michigan
$7.49M +$323K +2,171 +4%
HAIM
1022
Hunter Associates Investment Management
Pennsylvania
$7.49M -$48.3K -325 -0.6%
NEAM
1023
New England Asset Management
Connecticut
$7.48M -$57.3K -385 -0.7%
WTFG
1024
Wells Trecaso Financial Group
Ohio
$7.47M +$66.9K +450 +0.9%
APP
1025
Avantax Planning Partners
Iowa
$7.45M -$526K -3,534 -6%

JNJ Hedge Fund Activity: Q2 2024 in Review

3,802 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2024, worth a combined $249B — down 6.2% from $266B a quarter earlier.

Buyers outnumbered sellers: 162 funds opened new JNJ positions and 154 closed out — a net gain of 8 holders — while 1,507 added to existing stakes and 1,791 trimmed.

The largest buyer was BlackRock, adding an estimated $1.26B. The largest seller was Capital International Investors, cutting an estimated $1.8B.

  • 3,802 institutional investors held Johnson & Johnson (JNJ) as of Q2 2024, down from 3,849 in Q1 2024.
  • Funds reported $249B of Johnson & Johnson stock for Q2 2024, down 6.2% quarter-over-quarter.
  • 162 funds opened new Johnson & Johnson positions in Q2 2024 and 154 closed out, a net change of +8 holders.
  • The largest Johnson & Johnson buyer in Q2 2024 was BlackRock, an estimated $1.26B added.
  • The largest Johnson & Johnson seller in Q2 2024 was Capital International Investors, an estimated $1.8B sold.

Based on aggregated 13F filings for Q2 2024.